Lv5
1058 积分 2024-03-05 加入
The next generation of antibody–drug conjugates
3小时前
待确认
PF-08046876, a differentiated integrin beta-6 antibody-drug conjugate delivering a potent camptothecin payload optimized for bystander effect and reduced drug efflux
2天前
已完结
Clinical toxicity of ADCs and ICI–ADC combinations: mechanisms, patterns and management
2天前
已完结
Effects of Drug-Antibody Ratio on Pharmacokinetics, Biodistribution, Efficacy, and Tolerability of Antibody-Maytansinoid Conjugates
25天前
已完结
Improving Tumor Penetration of Antibodies and Antibody-Drug Conjugates: Taking Away the Barriers for Trojan Horses
25天前
已完结
Tumor Microenvironment-Responsive Antibody Fragment-Cleavable PEGylated Drug Conjugates (AFCDC) for Improved Tumor Penetration and Antitumor Efficacy
2个月前
已完结
Data from HRA00129-C004, a Novel c-Met Antibody–Drug Conjugate, Exerts Encouraging Antitumor Activities and Favorable Safety Profiles
2个月前
已完结
An exatecan derivative based linker-payload platform leads to ADC products with promising anti-tumor efficacy and potential low interstitial lung disease (ILD) risk
2个月前
已完结
Antibody−Drug Conjugates: Linking Cytotoxic Payloads to Monoclonal Antibodies
2个月前
已完结
Antibody Pharmacokinetics and Pharmacodynamics
2个月前
已完结